Stock comparison
Eli Lilly
Phibro Animal Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
PAHC
Phibro Animal Health
Market cap
$1.47B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | PAHC | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 41D | LLY |
| Benjamin Graham | 76B | 74B | LLY |
| Philip Fisher | 75B | 25F | LLY |
| Peter Lynch | 64C | 29F | LLY |
| Joel Greenblatt | 68B | 38D | LLY |
| Charlie Munger | 75B | 36D | LLY |
| Terry Smith | 66B | 32F | LLY |
Side-by-side metrics
| Metric | LLY | PAHC |
|---|---|---|
| Market cap | $946.37B | $1.47B |
| P/E (TTM) | 35.6x | 15.5x |
| EV/EBIT | 33.2x | 20.0x |
| ROIC (TTM) | 32.06% | 11.17% |
| Gross margin | 83.51% | 32.54% |
| Net margin | 34.98% | 6.35% |
| Revenue CAGR 5y | 23.17% | 11.68% |
| EPS CAGR 5y | 40.81% | -2.92% |
| Debt / Equity | 1.4x | 2.2x |
| Dividend yield | 0.64% | 1.32% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- EPS CAGR 5y40.81%vs -2.92%+107%
- Market cap$946.37Bvs $1.47B+100%
- Net margin34.98%vs 6.35%+82%
- ROIC (TTM)32.06%vs 11.17%+65%
PAHC leads on
- P/E (TTM)15.5xvs 35.6x+57%
- Dividend yield1.32%vs 0.64%+51%
- EV/EBIT20.0xvs 33.2x+40%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.